IL6 and inflammatory bowel disease: Pan et al. [35] reported that probiotic supplementation markedly reduced CRP and IL-6, mirroring findings in inflammatory bowel diseases such as ulcerative colitis, where probiotics modulate the intestinal microbiota and decrease epithelial permeability, thereby reducing systemic inflammation [50].